Exabis Library
Welcome to the e-CCO Library!
P261: Asking about bowel control problems in IBD: Results of face-to-face screening vs. self-reporting
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P261: Burden of bowel urgency across specific treatment groups among Ulcerative Colitis patients – real world global study analyses
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P261: Clinical predictors of a frequently relapsing disease course under 5-ASA amongst ulcerative colitis patients initially responding to induction therapy with 5-ASA and/or steroids
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P261: Frequency of B-cell subsets in infliximab-treated paediatric IBD patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P261: Grading post-operative recurrence in Crohn's disease: a comparison between MRE and ileocolonoscopy
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P261: Predictors and outcomes of ustekinumab dose escalation to every 4 or every 6 weeks in ulcerative colitis: a multicenter cohort study in the United States
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P261: Rate of Community Acquired Pneumonia, related hospitalization, and mortality among younger unvaccinated Inflammatory Bowel Disease patients
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P262 Trends in the prevalence and severity of anaemia in paediatric patients with inflammatory bowel disease in the last decade
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P262: Decreased infliximab trough levels (TLI) is a moderate predictor of loss of response to IFX in IBD patients.
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P262: Development and validation of a score predicting non-response to intravenous corticosteroids in patients with Acute Severe Ulcerative Colitis on day 3 of admission
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P262: Effectiveness and safety of ustekinumab in elderly patients: Real world evidence from ENEIDA registry
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P262: Evaluation of zinc as a biomarker of a complicated course in paediatric Crohn's disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P262: Influence of a positive family history on the clinical course of inflammatory bowel disease
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P262: New faecal calprotectin cut-off points for remission and active disease defined by UCEIS and Nancy indices in ulcerative colitis (UC)
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P262: Systematic review of development and content validity of patient-reported outcome measures in inflammatory bowel disease: do we measure what we measure?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P263 Proximal disease extension in patients with ulcerative proctitis: Associated factors and experience of an IBD tertiary Brazilian centre
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P263: De-novo inflammatory bowel disease after bariatric surgery: a novel association
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P263: Association between inflammatory bowel diseases and the non-classical histocompatibility complex HLA-G
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P263: Evaluation of fatigue in inflammatory bowel disease: a useful tool in daily practice
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P263: Influence of Crohn´s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM